Race Oncology Ltd. (AU:RAC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Race Oncology Ltd is set to hold its Annual General Meeting, where key updates on its lead asset, bisantrene, will be shared with shareholders. The company focuses on advancing bisantrene for cancer treatment, highlighting its unique safety profile and potential to meet unmet needs in oncology. Race Oncology is also seeking strategic partnerships to enhance global access to this promising asset.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.